Exact Mass: 424.1457
Exact Mass Matches: 424.1457
Found 78 metabolites which its exact mass value is equals to given mass value 424.1457
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Eprosartan
Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2776 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1].
4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-ylprop-1-enyl)-1-imidazolyl]methyl]benzoic acid
Ala Cys Met Thr
Ala Cys Thr Met
Ala Met Cys Thr
Ala Met Thr Cys
Ala Thr Cys Met
Ala Thr Met Cys
Cys Ala Met Thr
Cys Ala Thr Met
Cys Cys Ile Ser
Cys Cys Leu Ser
Cys Cys Ser Ile
Cys Cys Ser Leu
Cys Cys Thr Val
Cys Cys Val Thr
Cys Ile Cys Ser
Cys Ile Ser Cys
Cys Leu Cys Ser
Cys Leu Ser Cys
Cys Met Ala Thr
Cys Met Thr Ala
Cys Ser Cys Ile
Cys Ser Cys Leu
Cys Ser Ile Cys
Cys Ser Leu Cys
Cys Thr Ala Met
Cys Thr Cys Val
Cys Thr Met Ala
Cys Thr Val Cys
Cys Val Cys Thr
Cys Val Thr Cys
Gly Met Met Ser
Gly Met Ser Met
Gly Ser Met Met
Ile Cys Cys Ser
Ile Cys Ser Cys
Ile Ser Cys Cys
Leu Cys Cys Ser
Leu Cys Ser Cys
Leu Ser Cys Cys
Met Ala Cys Thr
Met Ala Thr Cys
Met Cys Ala Thr
Met Cys Thr Ala
Met Gly Met Ser
Met Gly Ser Met
Met Met Gly Ser
Met Met Ser Gly
Met Ser Gly Met
Met Ser Met Gly
Met Thr Ala Cys
Met Thr Cys Ala
Ser Cys Cys Ile
Ser Cys Cys Leu
Ser Cys Ile Cys
Ser Cys Leu Cys
Ser Gly Met Met
Ser Ile Cys Cys
Ser Leu Cys Cys
Ser Met Gly Met
Ser Met Met Gly
Thr Ala Cys Met
Thr Ala Met Cys
Thr Cys Ala Met
Thr Cys Cys Val
Thr Cys Met Ala
Thr Cys Val Cys
Thr Met Ala Cys
Thr Met Cys Ala
Thr Val Cys Cys
Val Cys Cys Thr
Val Cys Thr Cys
Val Thr Cys Cys
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfonyl]ethanone
7,7-dimethyl-1-(4-methylphenyl)-2,5-dioxo-N-(2-oxo-3-thiolanyl)-6,8-dihydroquinoline-3-carboxamide
Eprosartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1].